A recent meta-analysis including data from eight studies involving 81,178 subjects, which assessed the accuracy of AIP in predicting NAFLD, reported controversial results, the authors not finding statistically significant differences regarding the AIP levels between patients with NAFLD and the control subjects [48]. The gene discussed is AIP; the disease is metabolic dysfunction-associated steatotic liver disease.